LabVantage is committed to supporting our customers and minimizing any risks to you, our employees, and our communities during this global pandemic.
Please read our CEO’s message to learn what steps we are taking.
This support includes introducing LabVantage COVID-19 Biobanking LIMS, which deploys as a SaaS solution in as little as four weeks. Learn more.
The LabVantage Leadership Team continues to assess the pandemic and responds accordingly to developments and guidance from government and medical leaders, as well as developing solutions to help customers engaged in COVID-19 work.